Drammen sykehus   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Drammen Norway (1786)

Organization Overview

First Clinical Trial
2015
NCT02323412
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Drammen Hospital, Norway | Drammen Hospital - Vestre Viken | Drammen sykehus

Active Ingredients

Drugs in Phase 4 Trials (1)

carvedilol (coreg) (1 trial)

Drugs in Phase 3 Trials (2)

icosapent ethyl (vascepa) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Drugs in Phase 2 Trials (1)

osimertinib (tagrisso) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4